Screening for Down syndrome during the first and second trimesters: Impact of risk estimation parameters

This publication has 30 references indexed in Scilit:

• Prospective study of prenatal screening for Down's syndrome with free beta human chorionic gonadotrophin.
  BMJ, 1993
• The use of free β‐hCG in antenatal screening for Down's syndrome
  BJOG: An International Journal of Obstetrics and Gynaecology, 1993
• Free Beta Human Choriogonadotropin in Down's Syndrome Screening: A Multicentre Study of its Role Compared with other Biochemical Markers
  Annals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1992
• Prenatal Screening for Down's Syndrome with Use of Maternal Serum Markers
  New England Journal of Medicine, 1992
• Antenatal maternal serum screening for Down's syndrome: results of a demonstration project.
  BMJ, 1992
• Early Detection of Down's Syndrome Using Free Beta Human Choriogonadotropin
  Annals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1992
• Improved performance in a prenatal screening programme for Down's syndrome incorporating serum‐free hCG subunit analyses
  Prenatal Diagnosis, 1992
• Maternal serum screening for Down's syndrome: the effect of routine ultrasound scan determination of gestational age and adjustment for maternal weight
  BJOG: An International Journal of Obstetrics and Gynaecology, 1992
• Maternal serum Down syndrome screening: Free β-protein is a more effective marker than human chorionic gonadotropin
  American Journal of Obstetrics and Gynecology, 1990
• Maternal serum screening for Down's syndrome in early pregnancy.
  BMJ, 1988